Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAPPE: Low vs Standard Dose Intrapleural tPA for Pleural Infection
NCT05766124Phase 3Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Nov 2024
- Primary completion
- Mar 2026
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tissue-plasminogen activator in pleural infection, sponsored by The Chinese University of Hong Kong. Started Nov 2024; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
pleural infection
Beyond the preview
Go deeper on NCT05766124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05766124.